Search research articles
Contact Us
Filters
Showing results (171-180 of 199) with videos related to
Page
of 20
Sort By:
Nature Communications
|
October 8, 2025
Non-canonical dihydrolipoyl transacetylase promotes chemotherapy resistance via mitochondrial tetrahydrofolate signaling
Jung Seok Hwang, JiHoon Kang, Jaehyun Kim, et al.
Molecular and Cellular Biology
|
April 24, 2013
p90 RSK2 mediates antianoikis signals by both transcription-dependent and -independent mechanisms
Lingtao Jin, Dan Li, Jong Seok Lee, et al.
Current Cancer Drug Targets
|
March 18, 2014
Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts
Shijun Zhu, Terry W Moore, Nao Morii, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 28, 2020
YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed Phenotype
Taofeek K Owonikoko, Bhakti Dwivedi, Zhengjia Chen, et al.
Pharmaceutical Research
|
September 13, 2023
Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for Treatment of AML
James M Kelvin, Juhi Jain, Aashis Thapa, et al.
International Journal of Cancer
|
November 1, 2014
Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway
Sampath Ramachandiran, Arsene Adon, Xiangxue Guo, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
April 26, 2012
Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts
Shijun Zhu, Terry W Moore, Xiaoqian Lin, et al.
The Journal of Biological Chemistry
|
October 22, 2023
Discovery of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer's disease
Yuhong Du, William J Bradshaw, Tina M Leisner, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer's disease
Yuhong Du, William J Bradshaw, Tina M Leisner, et al.
The Journal of Clinical Investigation
|
March 26, 2024
Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers
Yueming Zhu, Anupam Banerjee, Ping Xie, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 199) with videos related to
Sort By:
Page
of 20
Nature Communications
|
October 8, 2025
Non-canonical dihydrolipoyl transacetylase promotes chemotherapy resistance via mitochondrial tetrahydrofolate signaling
Jung Seok Hwang, JiHoon Kang, Jaehyun Kim, et al.
Molecular and Cellular Biology
|
April 24, 2013
p90 RSK2 mediates antianoikis signals by both transcription-dependent and -independent mechanisms
Lingtao Jin, Dan Li, Jong Seok Lee, et al.
Current Cancer Drug Targets
|
March 18, 2014
Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts
Shijun Zhu, Terry W Moore, Nao Morii, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 28, 2020
YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed Phenotype
Taofeek K Owonikoko, Bhakti Dwivedi, Zhengjia Chen, et al.
Pharmaceutical Research
|
September 13, 2023
Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for Treatment of AML
James M Kelvin, Juhi Jain, Aashis Thapa, et al.
International Journal of Cancer
|
November 1, 2014
Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway
Sampath Ramachandiran, Arsene Adon, Xiangxue Guo, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
April 26, 2012
Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts
Shijun Zhu, Terry W Moore, Xiaoqian Lin, et al.
The Journal of Biological Chemistry
|
October 22, 2023
Discovery of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer's disease
Yuhong Du, William J Bradshaw, Tina M Leisner, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer's disease
Yuhong Du, William J Bradshaw, Tina M Leisner, et al.
The Journal of Clinical Investigation
|
March 26, 2024
Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers
Yueming Zhu, Anupam Banerjee, Ping Xie, et al.
Page
of 20